Recurrent Melanoma Terminated Phase 1 / 2 Trials for Cyclophosphamide (DB00531)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003552Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic MelanomaTreatment